Bharat Express

Petition Filed In Supreme Court Seeking Panel Of Medical Experts To Examine Covishield Side Effects

The application also requested that the Center be given instructions on how to recompense those who have died or are seriously injured as a result of the side effects of the corona vaccine they received during COVID 19.

A petition was made to the Supreme Court to establish a panel of medical experts to examine the side effects of the Covishield vaccination on Wednesday.

Vishal Tiwari, an advocate filed the plea and asked the court to order Center to create a vaccine damage payment scheme for the individuals who were disabled during the COVID-19 vaccination drive.

In the plea, attorney Vishal Tiwari asked for permission to form a panel of medical experts from the All India Institute of Medical Science, Delhi, to investigate the side effects and risk factors of the Covishield vaccine. The panel would be led by the director of the institute and supervised by a retired justice of the Supreme Court of India.

The application also requested that the Center be given instructions on how to recompense those who have died or are seriously injured as a result of the side effects of the corona vaccine they received during COVID 19.

In the application, advocate Vishal Tiwari mentioned the recent disclosure that the Covishield vaccine had caused and may cause side effects in rare cases, as its developer and pharmaceutical company AstraZeneca has said that its AZD1222 vaccine against COVID-19, which was made under licence in India as Covishield, could cause low platelet counts and formation of blood clots in “very rare” cases. AstraZeneca has accepted a link between the vaccine and Thrombosis with Thrombocytopenia Syndrome (TTS), a medical condition characterised by abnormally low levels of platelets and the formation of blood clots. AstraZeneca’s vaccine formula was licenced to Pune-based vaccine maker Serum Institute of India (SII) during the coronavirus pandemic for the manufacture of Covishield.

More than 175 crore doses of Covishield have been administered in India, advocate Vishal Tiwari said.

Advocate Tiwari, in the application, said that after COVID-19, there has been an increase in the cases of death due to heart attacks and sudden collapse of persons. “There have been a number of cases of heart attacks, even in youngsters. Now, after the document filed in UK court by the developer of Covishield, we are compelled to think upon the risk and hazardous consequences of the Covishield vaccine, which has been administered to citizens in large numbers (sic),” the application read.

“The government is required to take immediate steps for the sake of the safety and health of Indian Citizens. The issue has to be looked upon by the Union Government on priority so that in future no risk may occur regarding the health and life of Indian Citizens,” the application read.

Also Read: Delhi HC Rejects PIL For Virtual Campaigning By Arrested Political Leaders